•  
  •  
 

Keywords

Adrenal vein sampling, Catheterization, Primary aldosteronism, Hyperaldosteronism

Abstract

Adrenal vein sampling (AVS) is widely used for subtyping primary aldosteronism and guiding surgical decision-making. However, its interpretation is challenging, as protocols and interpretive indices vary widely across centers. In addition, several clinical and analytical conditions that can interfere with AVS interpretation may be underrecognized in clinical practice. This review summarizes the fundamental principles of AVS interpretation and discusses conditions that may confound diagnostic accuracy, as well as areas of ongoing controversy in contemporary practice.

References

1. Käyser SC, Dekkers T, Groenewoud HJ, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101(7):2826–2835.

2. Adler GK, Stowasser M, Correa RR, et al. Primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2025;110(9):2453–2495.

3. Monticone S, D’Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41– 50.

4. Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: Results of the PAPY Study. Hypertension. 2006;48(2):232–238.

5. Huang CW, Huang TY, Yang YF, et al. Major adverse cardiovascular events in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: A systematic review and meta-analysis. J Am Heart Assoc. 2025;14(3):e038714.

6. Nayak SS, Amini-Salehi E, Joukar F, et al. Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review. Int J Surg. 2024;110(11):7367–7380.

7. Farah MH, Hegazi M, Firwana M, et al. A systematic review supporting the Endocrine Society clinical practice guideline on management of primary aldosteronism. J Clin Endocrinol Metab. 2025;110(9):e2833–e2844.

8. Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to di erentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151(5):329–337.

9. Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC. Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization. N Engl J Med. 1967;277(20):1050–1056.

10. Daunt N. Adrenal vein sampling: How to make it quick, easy, and successful. Radiographics. 2005;25(Suppl 1):S143–S158.

11. Miotto D, De Toni R, Pitter G, et al. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension. 2009;54(4):885–889.

12. Nanba AT, Wannachalee T, Shields JJ, et al. Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism. J Clin Endocrinol Metab. 2019;104(2):487–492.

13. Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63(1): 151–160.

14. Nanba AT, Nanba K, Byrd JB, et al. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf). 2017;87(6):665–672.

15. Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022;18(11):665– 682.

16. Rossitto G, Amar L, Azizi M, et al. Subtyping of primary aldosteronism in the AVIS-2 study: Assessment of selectivity and lateralization. J Clin Endocrinol Metab. 2020;105(6):dgz017.

17. Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf). 2009;70(1):14–17.

18. Auchus RJ, Michaelis C, Wians FH Jr, et al. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009;249(2):318–321.

19. Betz MJ, Degenhart C, Fischer E, et al. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol. 2011;165(2):301–306.

20. Yozamp N, Hundemer GL, Moussa M, et al. Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: A retrospective cohort study and review of contemporary studies. Hypertension. 2021;78(1):94–103.

21. Wannachalee T, Zhao L, Nanba K, et al. Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling. J Clin Endocrinol Metab. 2019;104(12):5867–5876.

22. Lim JS, Plaska SW, Rege J, Rainey WE, Turcu AF. Aldosteroneregulating receptors and aldosterone-driver somatic mutations. Front Endocrinol (Lausanne). 2021;12:644382.

23. Rossi GP, Rossitto G, Amar L, et al. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension. 2019;74(4):800–808.

24. Vibhatavata P, Shields JJ, Rege J, Udager AM, Rainey WE, Turcu AF. Cosyntropin-stimulated aldosterone reserve of the nondominant adrenal predicts surgical outcomes in primary aldosteronism. Hypertension. 2025;82(10):1687–1695.

25. Turcu AF, Tezuka Y, Lim JS, et al. Multifocal, asymmetric bilateral primary aldosteronism cannot be excluded by strong adrenal vein sampling lateralization: An international retrospective cohort study. Hypertension. 2024;81(3):604–613.

26. Dominguez DA, Chatani P, Murphy R, et al. Contralateral suppression index does not predict clinical cure in patients undergoing surgery for primary aldosteronism. Ann Surg Oncol. 2021;28(12):7487–7495.

27. Monticone S, Satoh F, Viola A, et al. Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab. 2014;99(11):4158–4166.

28. Mørup S, Voss N, Clausen C, Feltoft CL, Andreassen M, Krogh J. Prognostic value of contralateral suppression for remission after surgery in patients with primary aldosteronism. Clin Endocrinol (Oxf). 2022;96(6):793–802.

29. Wolley MJ, Gordon RD, Ahmed AH, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab. 2015;100(4):1477–1484.

30. Vibhatavata P, Mermejo LM, Zhao L, Shields JJ, Turcu AF. Partially successful adrenal vein sampling with and without crosssectional imaging in primary aldosteronism subtyping. Hypertension. 2025 Dec 18. doi: 10.1161/HYPERTENSIONAHA.125. 26149. [Online ahead of print].

31. Desrochers MJ, St-Jean M, El Ghorayeb N, et al. Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism. Eur J Endocrinol. 2020;183(4):399–409.

32. Nakai K, Tsurutani Y, Inoue K, et al. Steroidogenic activity in unresected adrenals associated with surgical outcomes in primary aldosteronism. Hypertension. 2021;77(5):1638–1646.

33. DePietro DM, Fraker DL, Wachtel H, Cohen DL, Trerotola SO. "Double-down" adrenal vein sampling results in patients with apparent bilateral aldosterone suppression: utility of repeat sampling including super-selective sampling. J Vasc Interv Radiol. 2021;32(5):656–665.

34. Miyamoto S, Yoshida Y, Miyamoto S, Nishida H, Asayama Y, Shibata H. Segmental adrenal venous sampling in unilateral primary aldosteronism with apparent bilateral aldosterone suppression. JCEM Case Rep. 2024;2(9):luae164.

35. Viola A, Monticone S, Rossato D, et al. A case of adrenal vein sampling in primary aldosteronism with homolateral suppression. J Endocr Soc. 2017;1(5):401–406.

36. Shibayama Y, Wada N, Umakoshi H, et al. Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study. Clin Endocrinol (Oxf). 2016;85(5):696– 702.

37. Flanagan MJ, McDonald JH. Heterotopic adrenocortical adenoma producing primary aldosteronism. J Urol. 1967;98(2):133–139.

38. Ehrlich EN, Dominguez OV, Samuels LT, Lynch D, Oberhelman HJ, Warner NE. Aldosteronism and precocious puberty due to an ovarian androblastoma (Sertoli cell tumor). J Clin Endocrinol Metab. 1963;23(4):358–367.

39. Wannachalee T, Vibhatavata P, Konzen S, et al. Resolution of paradoxical bilateral aldosterone suppression with mass spectrometry. Eur J Endocrinol. 2025;192(4):511–518.

40. Li W, Zhou Q, He Y, et al. The value of LC-MS/MS in apparent bilateral aldosterone suppression in adrenal venous sampling for primary aldosteronism. J Clin Endocrinol Metab. 2025;110(9):e3011–e3020.

41. Vonend O, Ockenfels N, Gao X, et al. Adrenal venous sampling: Evaluation of the German Conn’s registry. Hypertension. 2011;57(5):990–995.

42. Pasternak JD, Epelboym I, Seiser N, et al. Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein. Surgery. 2016;159(1):267–273.

43. Lee SE, Park SW, Choi MS, et al. Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling. Ther Adv Endocrinol Metab. 2021;12:2042018821989239.

44. Lin L, Zhou L, Guo Y, et al. Can incomplete adrenal venous sampling data be used in predicting the subtype of primary aldosteronism? Ann Endocrinol (Paris). 2019;80(5–6):301-307.

45. Rossi GP, Bagordo D, Amar L, et al. Unilaterally selective adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension. 2023;80(10):2003– 2013.

46. Peng KY, Liao HW, Chan CK, et al. Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success. Hypertension. 2020;76(5):1537–1544.

47. Heinrich DA, Adolf C, Holler F, et al. Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact. J Clin Endocrinol Metab. 2019;104(11):5658–5664.

48. Fallo F, Castellano I, Gomez-Sanchez CE, et al. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series. Endocrine. 2017;58(3):503–512.

49. Ren K, Wei J, Liu Q, et al. Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report. BMC Endocr Disord. 2019;19(1):63.

50. Goupil R, Wolley M, Ahmed AH, Gordon RD, Stowasser M. Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism? Clin Endocrinol (Oxf). 2015;83(4):456–461.

51. O’Toole SM, Sze WC, Chung TT, et al. Low-grade cortisol cosecretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism. J Clin Endocrinol Metab. 2020;105(10):dgaa519.

52. Lamas C, Araujo-Castro M, Ostermair L, et al. Impact of cortisol-cosecretion on adrenal venous sampling results in primary aldosteronism: study of 225 cases. Biomedicines. 2024;12(11):2430.

53. Jiang Y, Zhou L, Zhang C, et al. The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism. Front Endocrinol (Lausanne). 2024;15:1369582.

54. Goupil R, Wolley M, Ungerer J, et al. Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion. Endocrinol Diabetes Metab Case Rep. 2015;2015:150075.

55. Heinrich DA, Quinkler M, Adolf C, et al. Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: A retrospective cohort study. Eur J Endocrinol. 2022;187(5):637–650.

56. Dekkers T, Deinum J, Schultzekool LJ, et al. Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertension. 2013;62(6):1152–1157.

57. Zhang X, Fu Y, Shen H, et al. Metanephrines-corrected adrenal vein sampling in primary aldosteronism concurrent with autonomous cortisol secretion. J Endocrinol Invest. 2025;48(11):2695–2702.

58. Remde H, Schaupp M, Fuss CT, et al. Reevaluating the use of metanephrine in adrenal vein sampling: A single centre retrospective study. Endocr Connect. 2025;14(10):e250402. doi: 10.1530/EC-25-0402.

59. Bu olo F, Pieroni J, Ponzetto F, et al. Prevalence of cortisol cosecretion in patients with primary aldosteronism: Role of metanephrine in adrenal vein sampling. J Clin Endocrinol Metab. 2023;108(9):e720–e725.

60. Kawahara EZ, Okubo J, Cavalcante A, et al. Adrenal venous sampling using metanephrine in primary aldosteronism with or without cortisol cosecretion. J Clin Endocrinol Metab. 2025;110(9):e2985–e2993.

61. Turcu AF, Wannachalee T, Tsodikov A, et al. Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping. Hypertension. 2020;75(1): 183–192.

62. Eisenhofer G, Durán C, Cannistraci CV, et al. Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism. JAMA Netw Open. 2020;3(9):e2016209.

63. Vékony B, Nyir˝o G, Herold Z, et al. Circulating miRNAs and machine learning for lateralizing primary aldosteronism. Hypertension. 2024;81(12):2479–2488.

64. Wu X, Senanayake R, Goodchild E, et al. [(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023;29(1):190–202.

65. Long T, Liu G, Zhou M, et al. First-in-human evaluation of [ 18 F]AldoView: A highly selective PET tracer for aldosterone synthase imaging in primary aldosteronism. Clin Nucl Med. 2025;50(9):847–855.

Download

Share

COinS